LIVN - LivaNova PLC
About LivaNova PLC (https://www.livanova.com)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Vladimir A. Makatsaria | Chief Executive Officer & Director | 1973 | $2,369,126 USD |
| Franco Poletti | President of Cardiopulmonary Business Unit | – | $1,133,359 USD |
| Alex Shvartsburg | Chief Financial Officer | 1970 | $1,120,910 USD |
| Natalia Kozmina | Chief Human Resources Officer | 1972 | $1,089,048 USD |
| Ahmet Tezel | Chief Innovation Officer | 1975 | $1,067,305 USD |
| Briana Gotlin | Vice President of Investor Relations | – | – |
| Deanna Wilke | Vice President of Corporate Communications | – | – |
| John Webb | Vice President of Sleep Apnea and Epilepsy | – | – |
| Lindsey Little | VP & Chief Accounting Officer | – | – |
| Lucile Blaise | Global Head of Commercialization - Obstructive Sleep Apnea (OSA) | 1971 | – |
| Paul R. Buckman | President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | 1956 | – |
| Philip Kowalczyk | Chief Strategy & Corporate Development Officer | – | – |
| Sarah Mohr | Secretary | – | – |
| Stephanie Bolton | President of Global Epilepsy | 1982 | – |
| Sujay Mashru | Senior Vice President of APAC & Growth Markets | – | – |